CEDEM AG Germany is the sole representative of the FIZ Frankfurt Biotechnology Innovation Center in the MENA region. The focus of FiZ synergy projects is placed on precision medicine and disruptive business models in the healthcare sector.
Precision medicine describes how genetic information is used to characterize a person’s disease, and provide doctors with more accurate diagnosis and treatment options; This in turn gives patients a higher rate of survival. Cancer is a disease of the genome, and as more is learned about cancer tumors, the more we can find that each tumor has its own set of genetic changes. Understanding the genetic changes in cancer cells is leading to more effective treatment strategies that are tailored to the genetic profile of each patient’s cancer.
For more information on the OptiCancer project and Precision Medicine, visit our website www.opticancer.net or our videos :